For patients and caregivers

Eczema (atopic dermatitis) clinical trials

Short answer: our physician practices run eczema research studies on a rolling basis, meaning studies open and close throughout the year. This page explains what these studies are like and who they may fit. Whether one is open for you right now depends on the specific study, and the first step is always a conversation, never a commitment.

What is eczema?

Eczema, also called atopic dermatitis, is a condition where the skin barrier does not hold moisture well and the immune system overreacts, causing dry, itchy, inflamed patches. It often starts in childhood but affects many adults, and the itch can disrupt sleep and daily life.

Who might these studies be for?

Adults and, in some studies, children whose eczema keeps returning despite creams and moisturizers, people with moderate-to-severe itch or widespread patches, and people interested in newer treatment approaches under study. A parent or guardian is always part of the conversation for anyone under 18. One honest boundary: not every person with this condition will qualify, and eligibility always depends on the specific study's criteria.

Is a study open right now?

Studies open and close on a rolling basis, so the honest answer changes month to month. Our dermatology practices in Texas, New Jersey, and New York see eczema every single day, in both adults and children. The fastest way to hear when something matches: join the registry once, and a coordinator contacts you when a fitting study opens, typically before public recruitment begins.

What does it cost, and is there compensation?

Study-related visits, exams, and investigational treatment come at no cost to you, and most studies compensate participants for time and travel. Specific compensation depends on the study and is explained clearly before you decide anything.

What happens after you enquire?

A coordinator contacts you, typically within one to two business days, for a plain-language conversation with no commitment attached. If a study fits, a screening visit follows, after an informed consent you can take home first. Participation is voluntary at every step, you can withdraw at any time for any reason, and your regular medical care never depends on your answer. The full walkthrough is in what happens at your first study visit and are clinical trials safe.

Interested, or just curious?

Both are fine. Join the registry, or email patients@stryderesearch.com with your questions; a real person answers.

Join the registry